NCT06372015 Changes in the Lipidomic, Immunological and miRNA Profile in Patients Undergoing a Dietary Program or Bariatric Surgery
| NCT ID | NCT06372015 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis |
| Condition | Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2024-06-01 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Obesity is a chronic disease characterized phenotypically by an increase in body weight (BMI\>30 kg/m2) and by a series of associated pathologies, such as hypertension, diabetes, hepatic steatosis. The association of these pathologies compromises the patient's survival and quality of life. The multifactorial origin of obesity makes its etiopathology difficult to manage. It is often possible to follow only one therapeutic strategy, especially after the so-called standard treatments, such as dietary intervention and physical activity, have not brought benefit to the patient. In these cases, an appropriate treatment for the patient to enjoy significant weight loss is bariatric surgery. Bariatric surgery refers to all those interventions aimed at reducing weight in those suffering from obesity, and treating the diseases associated with it. Among the different types of bariatric surgery, the techniques most used in common clinical practice are intragastric balloons, gastric by pass (RYGB) and sleeve gastrectomy. The choice of the surgeon, assisted by the multidisciplinary team, is binding in the choice of the type of operation to which the patient will be subjected.
Eligibility Criteria
Inclusion Criteria: * Obese patients (BMI \>30kg/m2) suffering from hepato-biliary pathology diagnosed by Fibroscan * Adult patients (\>18 years). Exclusion Criteria: * Patients who are not obese or not affected by hepato-biliary pathology
Contact & Investigator
Rossella Donghia, Biologyst
PRINCIPAL INVESTIGATOR
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Frequently Asked Questions
Who can join the NCT06372015 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06372015 currently recruiting?
Yes, NCT06372015 is actively recruiting participants. Contact the research team at rossella.donghia@irccsdebellis.it for enrollment information.
Where is the NCT06372015 trial being conducted?
This trial is being conducted at Castellana Grotte, Italy.
Who is sponsoring the NCT06372015 clinical trial?
NCT06372015 is sponsored by Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis. The principal investigator is Rossella Donghia, Biologyst at Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.